Translating vitamin D transcriptomics to clinical evidence: Analysis of data in asthma and chronic obstructive pulmonary disease, followed by clinical data meta-analysis
Vitamin D (VitD) continues to trigger intense scientific controversy, regarding both its bi ological targets and its supplementation doses and regimens. In an effort to resolve this dispute, we mapped VitD transcriptome-wide events in humans, in order to unveil shared patterns or mechanisms with diverse pathologies/tissue profiles and reveal causal effects between VitD actions and specific human diseases, using a recently developed bioinformatics methodology. Using the similarities in analyzed transcriptome data (c-SKL method), we validated our methodology with osteoporosis as an example and further analyzed two other strong hits, specifically chronic obstructive pulmonary disease (COPD) and asthma. The latter revealed no impact of VitD on known molecular pathways. In accordance to this finding, review and meta-analysis of published data, based on an objective measure (Forced Expiratory Volume at one second, FEV1%) did not further reveal any significant effect of VitD on the objective amelioration of either condition. This study may, therefore, be regarded as the first one to explore, in an objective, unbiased and unsupervised manner, the impact of VitD levels and/or interventions in a number of human pathologies.
%0 Journal Article
%1 noauthororeditor
%A Malliaraki, Niki
%A Lakiotaki, Kleanthi
%A Vamvoukaki, Rodanthi
%A Notas, George
%A Tsamardinos, Ioannis
%A Kampa, Marilena
%A Castanas, Elias
%D 2020
%J The Journal of Steroid Biochemistry and Molecular Biology
%K mxmcausalpath
%P 1-14
%R https://doi.org/10.1016/j.jsbmb.2019.105505
%T Translating vitamin D transcriptomics to clinical evidence: Analysis of data in asthma and chronic obstructive pulmonary disease, followed by clinical data meta-analysis
%U https://reader.elsevier.com/reader/sd/pii/S096007601930398X?token=BDFDFB0A2D6C3BCB2D6140BFCADFC9742EF3D905A0F5CFB518B320F4235CDDC6C6CF2A14B2FB25CB266333CBB3E631ED
%V 197
%X Vitamin D (VitD) continues to trigger intense scientific controversy, regarding both its bi ological targets and its supplementation doses and regimens. In an effort to resolve this dispute, we mapped VitD transcriptome-wide events in humans, in order to unveil shared patterns or mechanisms with diverse pathologies/tissue profiles and reveal causal effects between VitD actions and specific human diseases, using a recently developed bioinformatics methodology. Using the similarities in analyzed transcriptome data (c-SKL method), we validated our methodology with osteoporosis as an example and further analyzed two other strong hits, specifically chronic obstructive pulmonary disease (COPD) and asthma. The latter revealed no impact of VitD on known molecular pathways. In accordance to this finding, review and meta-analysis of published data, based on an objective measure (Forced Expiratory Volume at one second, FEV1%) did not further reveal any significant effect of VitD on the objective amelioration of either condition. This study may, therefore, be regarded as the first one to explore, in an objective, unbiased and unsupervised manner, the impact of VitD levels and/or interventions in a number of human pathologies.
@article{noauthororeditor,
abstract = {Vitamin D (VitD) continues to trigger intense scientific controversy, regarding both its bi ological targets and its supplementation doses and regimens. In an effort to resolve this dispute, we mapped VitD transcriptome-wide events in humans, in order to unveil shared patterns or mechanisms with diverse pathologies/tissue profiles and reveal causal effects between VitD actions and specific human diseases, using a recently developed bioinformatics methodology. Using the similarities in analyzed transcriptome data (c-SKL method), we validated our methodology with osteoporosis as an example and further analyzed two other strong hits, specifically chronic obstructive pulmonary disease (COPD) and asthma. The latter revealed no impact of VitD on known molecular pathways. In accordance to this finding, review and meta-analysis of published data, based on an objective measure (Forced Expiratory Volume at one second, FEV1%) did not further reveal any significant effect of VitD on the objective amelioration of either condition. This study may, therefore, be regarded as the first one to explore, in an objective, unbiased and unsupervised manner, the impact of VitD levels and/or interventions in a number of human pathologies.},
added-at = {2019-12-20T11:38:36.000+0100},
author = {Malliaraki, Niki and Lakiotaki, Kleanthi and Vamvoukaki, Rodanthi and Notas, George and Tsamardinos, Ioannis and Kampa, Marilena and Castanas, Elias},
biburl = {https://www.bibsonomy.org/bibtex/28cfb82678ba09a59927a27a148d1959f/mensxmachina},
doi = {https://doi.org/10.1016/j.jsbmb.2019.105505},
interhash = {5288b5fd5d047654c87ff505dfaa1814},
intrahash = {8cfb82678ba09a59927a27a148d1959f},
journal = {The Journal of Steroid Biochemistry and Molecular Biology},
keywords = {mxmcausalpath},
pages = {1-14},
timestamp = {2021-03-18T08:44:15.000+0100},
title = {Translating vitamin D transcriptomics to clinical evidence: Analysis of data in asthma and chronic obstructive pulmonary disease, followed by clinical data meta-analysis},
url = {https://reader.elsevier.com/reader/sd/pii/S096007601930398X?token=BDFDFB0A2D6C3BCB2D6140BFCADFC9742EF3D905A0F5CFB518B320F4235CDDC6C6CF2A14B2FB25CB266333CBB3E631ED},
volume = 197,
year = 2020
}